Completed
CARE Canadian ALS Riluzole Evaluation
NCT00542412
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Sanofi-Aventis Laval, Quebec, Canada